252 related articles for article (PubMed ID: 21114565)
1. Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis.
Schirmer L; Antel JP; Brück W; Stadelmann C
Brain Pathol; 2011 Jul; 21(4):428-40. PubMed ID: 21114565
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology.
Petzold A; Gveric D; Groves M; Schmierer K; Grant D; Chapman M; Keir G; Cuzner L; Thompson EJ
Exp Neurol; 2008 Oct; 213(2):326-35. PubMed ID: 18619438
[TBL] [Abstract][Full Text] [Related]
3. Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.
Schirmer L; Merkler D; König FB; Brück W; Stadelmann C
Brain Pathol; 2013 Jan; 23(1):2-12. PubMed ID: 22612622
[TBL] [Abstract][Full Text] [Related]
4. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Herrero-Herranz E; Pardo LA; Gold R; Linker RA
Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
[TBL] [Abstract][Full Text] [Related]
5. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
[TBL] [Abstract][Full Text] [Related]
6. Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords.
Androdias G; Reynolds R; Chanal M; Ritleng C; Confavreux C; Nataf S
Ann Neurol; 2010 Oct; 68(4):465-76. PubMed ID: 20687208
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial changes within axons in multiple sclerosis.
Mahad DJ; Ziabreva I; Campbell G; Lax N; White K; Hanson PS; Lassmann H; Turnbull DM
Brain; 2009 May; 132(Pt 5):1161-74. PubMed ID: 19293237
[TBL] [Abstract][Full Text] [Related]
8. Axonal loss in the multiple sclerosis spinal cord revisited.
Petrova N; Carassiti D; Altmann DR; Baker D; Schmierer K
Brain Pathol; 2018 May; 28(3):334-348. PubMed ID: 28401686
[TBL] [Abstract][Full Text] [Related]
9. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Brück W
Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
[TBL] [Abstract][Full Text] [Related]
10. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
Wegner C
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
[TBL] [Abstract][Full Text] [Related]
11. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
Bannerman PG; Hahn A
J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
Gray E; Rice C; Nightingale H; Ginty M; Hares K; Kemp K; Cohen N; Love S; Scolding N; Wilkins A
Mult Scler; 2013 Feb; 19(2):153-61. PubMed ID: 22723571
[TBL] [Abstract][Full Text] [Related]
13. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.
Huizinga R; Gerritsen W; Heijmans N; Amor S
Neurobiol Dis; 2008 Dec; 32(3):461-70. PubMed ID: 18804534
[TBL] [Abstract][Full Text] [Related]
14. Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and α-internexin immunoreactivity.
King AE; Blizzard CA; Southam KA; Vickers JC; Dickson TC
Brain Res; 2012 Jul; 1465():90-100. PubMed ID: 22609817
[TBL] [Abstract][Full Text] [Related]
15. Axonal damage in the making: neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter.
Petzold A; Tozer DJ; Schmierer K
Exp Neurol; 2011 Dec; 232(2):234-9. PubMed ID: 21958956
[TBL] [Abstract][Full Text] [Related]
16. Axonal changes in chronic demyelinated cervical spinal cord plaques.
Lovas G; Szilágyi N; Majtényi K; Palkovits M; Komoly S
Brain; 2000 Feb; 123 ( Pt 2)():308-17. PubMed ID: 10648438
[TBL] [Abstract][Full Text] [Related]
17. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
Wolswijk G; Balesar R
Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
[TBL] [Abstract][Full Text] [Related]
18. Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis.
Huizinga R; van der Star BJ; Kipp M; Jong R; Gerritsen W; Clarner T; Puentes F; Dijkstra CD; van der Valk P; Amor S
Glia; 2012 Mar; 60(3):422-31. PubMed ID: 22161990
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease.
Leitzen E; Jin W; Herder V; Beineke A; Elmarabet SA; Baumgärtner W; Hansmann F
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823515
[TBL] [Abstract][Full Text] [Related]
20. Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.
Rahmanzadeh R; Lu PJ; Barakovic M; Weigel M; Maggi P; Nguyen TD; Schiavi S; Daducci A; La Rosa F; Schaedelin S; Absinta M; Reich DS; Sati P; Wang Y; Bach Cuadra M; Radue EW; Kuhle J; Kappos L; Granziera C
Brain; 2021 Jul; 144(6):1684-1696. PubMed ID: 33693571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
